alea-institute/kl3m-data-sample-004-shuffled huggingface dataset:
CERTIFICATION PURSUANT TO
                            18 U.S.C. SECTION 1350,
                             AS ADOPTED PURSUANT TO
                 SECTION 906 OF THE SARBANES-OXLEY ACT OF 2002



     In connection with the Quarterly  Report of Tonga Capital  Corporation (the
"Company") on Form 10-QSB for the period ending March 31, 2005 as filed with the
Securities and Exchange Commission on the date hereof (the "Report"). I, Jeffrey
Ploen, CEO of the company,  certify, pursuant to 18 USC Section 1350, as adopted
pursuant to Section 906 of the  Sarbanes-Oxley  Act of 2002, that to the best of
my knowledge and belief.

        (1)     The Report fully complies with the requirements of Section 13(a)
                or 15(d) of the Securities Exchange Act of 1934; and

        (2)     The information contained in the Report fairly presents, in all
                material respects, the financial condition and results of
                operations of the Company.




                                         /s/ Jeffrey Ploen
                                         --------------------------------
                                         Jeffrey Ploen, CEO

Dated: May 19, 2005
# C_2019195EN.01000401.xml

| 11.6.2019 | EN | Official Journal of the European Union | C 195/4 |
| --- | --- | --- | --- |

11.6.2019

EN

Official Journal of the European Union

C 195/4

---

COUNCIL DECISION

of 6 June 2019

appointing the government members and alternate members of the Management Board of the European Agency for Safety and Health at Work for Greece, France and Luxembourg

(2019/C 195/03)

THE COUNCIL OF THE EUROPEAN UNION,

Having regard to the Treaty on the Functioning of the European Union,

Having regard to Regulation (EU) 2019/126 of the European Parliament and of the Council of 16 January 2019 establishing the European Agency for Safety and Health at Work (EU-OSHA) and repealing Council Regulation (EC) No 2062/94 (1), and in particular Article 4 thereof,

Having regard to the lists of nominations for appointment submitted to the Council by the Governments of the Member States and by the employees’ and the employers’ organisations,

Having regard to the lists of members and alternate members of the Advisory Committee on Safety and Health at Work,

Whereas:

| (1) | By its Decision of 9 April 2019 (2), the Council appointed the members and alternate members of the Management Board of the European Agency for Safety and Health at Work for the period from 1 April 2019 to 31 March 2023. |
| --- | --- |

(1)

By its Decision of 9 April 2019 (2), the Council appointed the members and alternate members of the Management Board of the European Agency for Safety and Health at Work for the period from 1 April 2019 to 31 March 2023.

| (2) | The Governments of Greece, France and Luxembourg have submitted further nominations for several posts to be filled, |
| --- | --- |

(2)

The Governments of Greece, France and Luxembourg have submitted further nominations for several posts to be filled,

HAS ADOPTED THIS DECISION:

Article 1

The following are hereby appointed members and alternate members of the Management Board of the European Agency for Safety and Health at Work for the period ending on 31 March 2023:

I.   GOVERNMENT REPRESENTATIVES

| Country | Members | Alternate members |
| --- | --- | --- |
| Greece | Mr Ioannis KONSTANTAKOPOULOS | Mr Georgios GOURZOULIDIS |
| France | Ms Lucie MEDIAVILLA | Ms Amel HAFID |
| Luxembourg | Mr Marco BOLY | Ms Patrice FURLANI |

Country

Members

Alternate members

Greece

Mr Ioannis KONSTANTAKOPOULOS

Mr Georgios GOURZOULIDIS

France

Ms Lucie MEDIAVILLA

Ms Amel HAFID

Luxembourg

Mr Marco BOLY

Ms Patrice FURLANI

Article 2

The Council shall appoint the members and alternate members not yet nominated at a later date.

Article 3

This Decision shall enter into force on the date of its adoption.

Done at Luxembourg, 6 June 2019.

For the Council

The President

A. BIRCHALL

---

(1)  OJ L 30, 31.1.2019, p. 58.

1

(2)  Council Decision of 9 April 2019 appointing the members and alternate members of the Management Board of the European Agency for Safety and Health at Work (EU-OSHA) (OJ C 135, 11.4.2019, p 7).

2

---
#### § 1230.32 Analyzing of samples.

Samples collected by an authorized agent shall be analyzed at the laboratory designated by the Food and Drug Administration. Only such samples as are collected in accordance with §§ 1230.30, 1230.31 may be analyzed by or under the direction and supervision of the Food and Drug Administration. Upon request one subdivision of the sample, if available, shall be delivered to the party or parties interested.
# L_2019192EN.01002301.xml

| 18.7.2019 | EN | Official Journal of the European Union | L 192/23 |
| --- | --- | --- | --- |

18.7.2019

EN

Official Journal of the European Union

L 192/23

---

COUNCIL DECISION (EU, Euratom) 2019/1214

of 15 July 2019

appointing a member, proposed by the Kingdom of Sweden, of the European Economic and Social Committee

THE COUNCIL OF THE EUROPEAN UNION,

Having regard to the Treaty on the Functioning of the European Union, and in particular Article 302 thereof,

Having regard to the Treaty establishing the European Atomic Energy Community, and in particular Article 106a thereof,

Having regard to the proposal of the Swedish Government,

Having regard to the opinion of the European Commission,

Whereas:

| (1) | On 18 September 2015 and 1 October 2015, the Council adopted Decisions (EU, Euratom) 2015/1600 (1) and (EU, Euratom) 2015/1790 (2) appointing the members of the European Economic and Social Committee for the period from 21 September 2015 to 20 September 2020. |
| --- | --- |

(1)

On 18 September 2015 and 1 October 2015, the Council adopted Decisions (EU, Euratom) 2015/1600 (1) and (EU, Euratom) 2015/1790 (2) appointing the members of the European Economic and Social Committee for the period from 21 September 2015 to 20 September 2020.

| (2) | A member's seat on the European Economic and Social Committee has become vacant following the end of the mandate of Mr Frank Thomas ABRAHAMSSON, |
| --- | --- |

(2)

A member's seat on the European Economic and Social Committee has become vacant following the end of the mandate of Mr Frank Thomas ABRAHAMSSON,

HAS ADOPTED THIS DECISION:

Article 1

Mr Sam HÄGGLUND, European Federation of Building and Woodworkers, is hereby appointed as a member of the European Economic and Social Committee for the remainder of the current term of office, which runs until 20 September 2020.

Article 2

This Decision shall enter into force on the date of its adoption.

Done at Brussels, 15 July 2019.

For the Council

The President

J. LEPPÄ

---

(1)  Council Decision (EU, Euratom) 2015/1600 of 18 September 2015 appointing the members of the European Economic and Social Committee for the period from 21 September 2015 to 20 September 2020 (OJ L 248, 24.9.2015, p. 53).

1

(2)  Council Decision (EU, Euratom) 2015/1790 of 1 October 2015 appointing the members of the European Economic and Social Committee for the period from 21 September 2015 to 20 September 2020 (OJ L 260, 7.10.2015, p. 23).

2

---
Exhibit
22.1
  CONSENT
OF INDEPENDENT REGISTERED PUBLIC ACCOUNTING FIRM
 
 
 To the
Board of Directors of
 Cicero
Inc.
 
 We
consent to the incorporation by reference in the Annual Report on Form 10-K of
Cicero Inc and subsidiaries for the years ended December 31, 2007 and 2006 of
our report dated March 31, 2008, (which report expresses an unqualified opinion
relating to the financial statements for the three years ended December 31,
2008, 2007 and 2006.
  
 /s/Margolis
      & Company P.C.Certified
      Public Accountants
 
 
 Bala
Cynwyd, PA
 March 31,
2009
<TABLE> <S> <C>

<ARTICLE> 5
<CIK> 0000945800
<NAME> DOMINICK'S FINER FOODS, INC.
<MULTIPLIER> 1000
       
<S>                             <C>
<PERIOD-TYPE>                   12-MOS
<FISCAL-YEAR-END>                          NOV-02-1996
<PERIOD-START>                             OCT-29-1995
<PERIOD-END>                               NOV-02-1996
<CASH>                                          32,735
<SECURITIES>                                         0
<RECEIVABLES>                                   16,723
<ALLOWANCES>                                         0
<INVENTORY>                                    203,411
<CURRENT-ASSETS>                               274,729
<PP&E>                                         416,703
<DEPRECIATION>                                  48,479
<TOTAL-ASSETS>                               1,102,205
<CURRENT-LIABILITIES>                          308,434
<BONDS>                                              0
<PREFERRED-MANDATORY>                                0
<PREFERRED>                                          0
<COMMON>                                             1
<OTHER-SE>                                     179,071
<TOTAL-LIABILITY-AND-EQUITY>                 1,102,205
<SALES>                                      2,511,962
<TOTAL-REVENUES>                             2,511,962
<CGS>                                        1,932,994
<TOTAL-COSTS>                                1,932,994
<OTHER-EXPENSES>                                     0
<LOSS-PROVISION>                                     0
<INTEREST-EXPENSE>                              70,296
<INCOME-PRETAX>                                  6,813
<INCOME-TAX>                                     7,385
<INCOME-CONTINUING>                              (572)
<DISCONTINUED>                                       0
<EXTRAORDINARY>                                (6,360)
<CHANGES>                                            0
<NET-INCOME>                                   (6,932)
<EPS-PRIMARY>                                  (6,932)
<EPS-DILUTED>                                  (6,932)
        

</TABLE>
TEXAS COURT OF APPEALS, THIRD DISTRICT, AT AUSTIN

NO. 03-03-00523-CV

Texas Workforce Commission; Diane D. Rath, in her capacity as Chairman of the Texas

Workforce Commission; Commissioner Terrence P. O’Mahoney; Commissioner Ron

Lehman; Executive Director Cassie Carlson Reed, Appellants

v.

Center for Public Policy Priorities, Appellee

FROM THE DISTRICT COURT OF TRAVIS COUNTY, 345TH JUDICIAL DISTRICT

NO. GN303148, HONORABLE DARLENE BYRNE, JUDGE PRESIDING 

M E M O R A N D U M O P I N I O N

Appellantsfiled a motion to dismissthis appeal because the parties have entered into

an “Agreed Final Order Granting Dismissal” of their claims in the trial court, thus mooting this

appeal. Accordingly, we grant the motion and dismiss the appeal. See Tex. R. App. P. 42.1(a)(1).

 

W. Kenneth Law, Chief Justice

Before Chief Justice Law, Justices B. A. Smith and Patterson

Dismissed on Appellants’ Motion

Filed: January 29, 2004
2
From: Daisy Cantu/FTEHSF [mailto:DaisyC@ftpc.fpcusa.com]

Sent: Friday, August 15, 2014 6:03 PM To: Howard, Jodi Cc: Mary Bachynsky/FPC Environmental Dept.; Stephanie Schmidt/FTEHSF; Eddie Houseton/FTSPSF; Daisy Cantu/FTEHSF; Mario Troncoso/FTEHSF Subject: Formosa Plastics Corporation, Texas

- PVC MACT S114 Form H

Ms. Howard,

Attached is the updated PVC MACT S114 Form H for Formosa Plastics Corporation, Texas. Let us know if you need anything else to get this information officially

recog nized. Also, please confirm that you received this email.

Regards,

Daisy N. Cantu Environmental, Health & Safety Formosa Plastics Corporation, Texas Point Comfort, Texas Office: (361) 987

- 8752

E

- mail: DaisyC@ftpc.fpcusa.com

____________________________________________________________ This communication is solely for use by the intended recipient and may contain information that is privileged, confidential or copyrighted under applicable law. If you are not the
intended r ecipient, you are hereby formally notified that any use, copying or distribution of this communication, in whole or in part, is strictly prohibited. Unless explicitly stated, this communication does not constitute a contract offer, a contract amendment , or an acceptance of a contract offer. This communication also does not
constitute consent to the use of sender's contact information for direct marketing purposes or for transfers of data to third parties.
§ 310.528 Drug products containing active ingredients offered over-the-counter (OTC) for use as an aphrodisiac. ( a ) Any product that bears labeling claims that it will arouse or increase sexual desire, or that it will improve sexual performance, is an aphrodisiac drug product. Anise, cantharides, don qual, estrogens, fennel, ginseng, golden seal, gotu kola, Korean ginseng, licorice, mandrake, methyltestosterone, minerals, nux vomica, Pega Palo, sarsaparilla, strychnine, testosterone, vitamins, yohimbine, yohimbine hydrochloride, and yohimbinum have been present as ingredients in such drug products. Androgens (e.g., testosterone and methyltestosterone) and estrogens are powerful hormones when administered internally and are not safe for use except under the supervision of a physician. There is a lack of adequate data to establish general recognition of the safety and effectiveness of any of these ingredients, or any other ingredient, for OTC use as an aphrodisiac. Labeling claims for aphrodisiacs for OTC use are either false, misleading, or unsupported by scientific data. The following claims are examples of some that have been made for aphrodisiac drug products for OTC use: “acts as an aphrodisiac;” “arouses or increases sexual desire and improves sexual performance;” “helps restore sexual vigor, potency, and performance;” “improves performance, staying power, and sexual potency;” and “builds virility and sexual potency.” Based on evidence currently available, any OTC drug product containing ingredients for use as an aphrodisiac cannot be generally recognized as safe and effective.
( b ) Any OTC drug product that is labeled, represented, or prompted for use as an aphrodisiac is regarded as a new drug within the meaning of section 201(p) of the Federal Food, Drug, and Cosmetic Act, (the act), for which an approved new drug application under section 505 of the act and part 314 of this chapter is required for marketing. In the absence of an approved new drug application, such product is also misbranded under section 502 of the act.
( c ) Clinical investigations designed to obtain evidence that any drug product labeled, represented, or promoted for OTC use as an aphrodisiac is safe and effective for the purpose intended must comply with the requirements and procedures governing the use of investigational new drugs set forth in part 312 of this chapter.
( d ) After January 8, 1990, any such OTC drug product initially introduced or initially delivered for introduction into interstate commerce that is not in compliance with this section is subject to regulatory action.
[54 FR 28786, July 7, 1989]
N OTE : This disposition is nonprecedential.



# United States **Court of Appeals** 
**for the Federal Circuit**

______________________

JI

- SOO LEE, Appellant

v.

GOOGLE LLC, Appellee

______________________

2021

- 1576

______________________

Appeal from the United States Patent and Trademark Office, Patent Trial and Appeal Board in No. IPR2016

- 00045.

______________________

JUDGMENT

______________________

B ENJAMIN E. M ASKELL

, Maskell Law PLLC, Arlington, VA, argued for appellant. Also represented by S EONG -D ON
H WANG , Woodbridge, VA.

L UANN L ORAINE S IMMONS

, O'Melveny & Myers LLP, San Francisco, CA, argued for appellee. Also represented by D AVID A LMELING

, D ARIN W. S NYDER

, B ILL T RAC ; M ICHAEL T IMOTHY H AWKINS , Fish & Richardson PC, Minneapolis, MN.

______________________ Case: 21-1576 Document: 57 Page: 1 Filed: 04/14/2022T HIS C AUSE ha ving been heard and considered, it is

O RDERED and A DJUDGED :

P ER C URIAM (L OURIE

, P ROST

, and C HEN

, Ci rcuit Judges ).

AFFIRMED. See Fed . Cir. R. 36.

E NTERED BY O RDER OF THE C OURT

April 14, 2022

Date /s/ Peter R. Marksteiner

Peter R. Marksteiner
Clerk of Court Case: 21-1576 Document: 57 Page: 2 Filed: 04/14/2022
<PAGE>   1
                       CONSENT OF INDEPENDENT ACCOUNTANTS

We hereby consent to the incorporation by reference in the Registration
Statement on Form S-8 (No. 333-43685) and in the Prospectus constituting part
of the Registration Statement on Form S-3 (No. 333-52245) of Data Dimensions,
Inc. of our report dated July 13, 1998 relating to the financial statements of
ST Labs, Inc., which appears in the Current Report on Form 8-K of Data 
Dimensions, Inc. dated August 6, 1998.

PRICEWATERHOUSECOOPERS LLP
Seattle, Washington
August 4, 1998
<PAGE>   1
                                                                    EXHIBIT 2.02



                              CERTIFICATE OF MERGER

        The undersigned, the President of Chinook Acquisition Corporation, a
Delaware corporation, hereby certifies in connection with the merger of
GenQuest, Inc. and Chinook Acquisition Corporation that:

        1. The name and state of incorporation of each of the constituent
corporations of the merger are as follows:

               NAME                                   STATE OF INCORPORATION

               Chinook Acquisition Corporation               Delaware
               GenQuest, Inc.                                Delaware

        2. An agreement and plan of merger has been approved, adopted,
certified, executed and acknowledged by each of the constituent corporations in
accordance with the requirements of Section 251 of the General Corporation Law
of the State of Delaware.

        3. The name of the surviving corporation of the merger is Chinook
Acquisition Corporation.

        4. The certificate of incorporation of Chinook Acquisition Corporation,
the surviving corporation, shall be the certificate of incorporation of the
surviving corporation.

        5. The executed agreement and plan of merger is on file at the office of
the surviving corporation. The address of the office of the surviving
corporation at which the agreement of merger is filed is 1124 Columbia Street,
Suite 200, Seattle, WA 98104.

        6. A copy of the agreement and plan of merger will be furnished by the
surviving corporation, on request and without cost, to any stockholder of any
constituent corporation.

        Chinook Acquisition Corporation has caused the Certificate to be signed
by _________________ its authorized officer, this _____ day of ___________, 1998



                                            Chinook Acquisition Corporation

                                            By:_________________________________
                                               President
<PAGE>   1
                                                                    EXHIBIT 23.2

                        Consent of Independent Auditors

We consent to the reference to our firm under the caption "Experts" and to the
use of our report dated March 16, 1999, with respect to the consolidated
financial statements of The Ackerley Group, Inc. and our report dated April 12,
1999, with respect to the financial statements of WOKR(TV) included in the
Registration Statement (Form S-3 No. 333-49711) and related Prospectus of The
Ackerley Group, Inc. for the registration of 4,830,000 shares of its common
stock.

                                                           /s/ Ernst & Young LLP

Seattle, Washington
June 17, 1999
Exhibit







Exhibit 10.1







March 8, 2017


John Mansanti
Senior Vice President of Strategic Initiatives and Technical Services
Intrepid Potash, Inc.
707 17th Street, Suite 4200
Denver, CO 80202        


		
	Re: 
	Termination of Change-in-Control Severance Agreement




John:


In connection with your transition to a 60% work schedule, you and Intrepid Potash, Inc. (“Intrepid”) have agreed to terminate the Change-in-Control Severance Agreement, dated February 24, 2010, between you and Intrepid (the “Agreement”).


In accordance with Section 2 of the Agreement, you and Intrepid hereby agree to terminate the Agreement effective as of March 8, 2017.  


Sincerely,
Intrepid Potash, Inc.


By:    /s/ James N. Whyte            
Name:    James N. Whyte
Title:    Executive Vice President


Agreed to:


John G. Mansanti




By:    /s/ John G. Mansanti            
Date:    March 22, 2017
Exhibit 32.2




                            CERTIFICATION PURSUANT TO
                            18 U.S.C. SECTION 1350,
                             AS ADOPTED PURSUANT TO
                 SECTION 906 OF THE SARBANES-OXLEY ACT OF 2002



     In  connection  with the  Quarterly  Report  of  Tonga  Capital  Corp  (the
"Company")  on Form  10-QSB/A for the period  ending June 30, 2006 as filed with
the Securities  and Exchange  Commission on the date hereof (the  "Report").  I,
Stuart C. Cater, Chief Financial Officer of the company, certify, pursuant to 18
USC Section 1350, as adopted pursuant to Section 906 of the  Sarbanes-Oxley  Act
of 2002, that to the best of my knowledge and belief.

        (1)     The Report fully complies with the requirements of Section 13(a)
                or 15(d) of the Securities Exchange Act of 1934; and

        (2)     The information  contained in the Report fairly presents, in all
                material  respects,  the  financial  condition  and  results  of
                operations of the Company.




                                        /s/ Stuart C. Cater
                                        --------------------------------
                                        Stuart C. Cater, Chief Financial Officer
Dated: April 10, 2007
```

[Federal Register Volume 80, Number 79 (Friday, April 24, 2015)]
[Notices]
[Page 22968]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: 2015-09494]

[[Page 22968]]

=======================================================================
-----------------------------------------------------------------------

COMMISSION ON CIVIL RIGHTS

Agenda and Notice of Public Meeting of the Texas Advisory 
Committee

    Notice is hereby given, pursuant to the provisions of the rules and 
regulations of the U.S. Commission on Civil Rights (Commission) and the 
Federal Advisory Committee Act (FACA) that a meeting of the Texas 
Advisory Committee (Committee) to the Commission will be held on 
Friday, May 8, 2015, at the Lone Star Legal Aid, 1415 Fannin Street, 
Houston, TX 77002.
    The meeting is scheduled to begin at 1:30 p.m. and adjourn at 
approximately 3:00 p.m. The purpose of the meeting is for the members 
of the Committee to receive an orientation regarding state advisory 
committee procedures and to plan future activities.
    Members of the public are entitled to submit written comments. The 
comments must be received in the Western Regional Office of the 
Commission by June 8, 2015. The address is Western Regional Office, 
U.S. Commission on Civil Rights, 300 N. Los Angeles Street, Suite 2010, 
Los Angeles, CA 90012. Persons wishing to email their comments may do 
so by sending them to Angelica Trevino, Civil Rights Analyst, Western 
Regional Office, at atrevino@usccr.gov. Persons who desire additional 
information should contact the Western Regional Office, at (213) 894-
3437, (or for hearing impaired TDD 913-551-1414), or by email to 
atrevino@usccr.gov. Hearing-impaired persons who will attend the 
meeting and require the services of a sign language interpreter should 
contact the Regional Office at least ten (10) working days before the 
scheduled date of the meeting.
    Records generated from this meeting may be inspected and reproduced 
at the Western Regional Office, as they become available, both before 
and after the meeting. Persons interested in the work of this advisory 
committee are advised to go to the Commission's Web site, 
www.usccr.gov, or to contact the Western Regional Office at the above 
email or street address. The meeting will be conducted pursuant to the 
provisions of the rules and regulations of the Commission and FACA.

    Dated: April 20, 2015.
David Mussatt,
Chief, Regional Programs Coordination Unit.
[FR Doc. 2015-09494 Filed 4-23-15; 8:45 am]
 BILLING CODE 6335-01-P
```